NO910213L - PROCEDURE FOR THE PREPARATION OF ORAL PHARMACEUTICAL FORMS OF PIMOBENDAN. - Google Patents

PROCEDURE FOR THE PREPARATION OF ORAL PHARMACEUTICAL FORMS OF PIMOBENDAN.

Info

Publication number
NO910213L
NO910213L NO91910213A NO910213A NO910213L NO 910213 L NO910213 L NO 910213L NO 91910213 A NO91910213 A NO 91910213A NO 910213 A NO910213 A NO 910213A NO 910213 L NO910213 L NO 910213L
Authority
NO
Norway
Prior art keywords
pimobendan
procedure
preparation
oral pharmaceutical
pharmaceutical forms
Prior art date
Application number
NO91910213A
Other languages
Norwegian (no)
Other versions
NO176305B (en
NO176305C (en
NO910213D0 (en
Inventor
Peter Gruber
Willy Roth
Gottfried Schepky
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of NO910213D0 publication Critical patent/NO910213D0/en
Publication of NO910213L publication Critical patent/NO910213L/en
Publication of NO176305B publication Critical patent/NO176305B/en
Publication of NO176305C publication Critical patent/NO176305C/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Abstract

Pimobendan dosage forms for oral administration contain citric acid, ensuring constantly good absorption even with large pH variations in the gastrointestinal tract.
NO910213A 1990-01-20 1991-01-18 Process for the preparation of oral pharmaceutical forms of pimobendan NO176305C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4001622A DE4001622A1 (en) 1990-01-20 1990-01-20 ORAL DRUGS OF PIMOBENDAN

Publications (4)

Publication Number Publication Date
NO910213D0 NO910213D0 (en) 1991-01-18
NO910213L true NO910213L (en) 1991-07-22
NO176305B NO176305B (en) 1994-12-05
NO176305C NO176305C (en) 1995-03-15

Family

ID=6398467

Family Applications (1)

Application Number Title Priority Date Filing Date
NO910213A NO176305C (en) 1990-01-20 1991-01-18 Process for the preparation of oral pharmaceutical forms of pimobendan

Country Status (18)

Country Link
EP (1) EP0439030B1 (en)
JP (1) JP2608183B2 (en)
KR (1) KR0163056B1 (en)
AT (1) ATE87481T1 (en)
AU (1) AU630536B2 (en)
CA (1) CA2034569C (en)
DE (2) DE4001622A1 (en)
DK (1) DK0439030T3 (en)
ES (1) ES2054379T3 (en)
FI (1) FI96274C (en)
HK (1) HK175796A (en)
HU (1) HU207948B (en)
IE (1) IE64659B1 (en)
IL (1) IL96995A (en)
NO (1) NO176305C (en)
NZ (1) NZ236834A (en)
PT (1) PT96506B (en)
ZA (1) ZA91372B (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2753904B1 (en) * 1996-10-01 1998-10-30 Gattefosse Ets Sa PHARMACEUTICAL COMPOSITION WITH MODIFIED RELEASE OF ACTIVE SUBSTANCE, INCLUDING A MATRIX, AND MANUFACTURING PROCESS
DE102004011512B4 (en) 2004-03-08 2022-01-13 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical preparation containing pimobendan
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
WO2005107719A2 (en) * 2004-05-06 2005-11-17 Sandoz Ag Pharmaceutical composition comprising hydrophobic drug having improved solubility
JP3996626B2 (en) * 2004-06-22 2007-10-24 塩野義製薬株式会社 Orally disintegrating tablets
JP4572296B2 (en) * 2004-07-21 2010-11-04 トーアエイヨー株式会社 Pimobendan oral dosage formulation
JP2006028130A (en) * 2004-07-21 2006-02-02 Toa Eiyo Ltd Pimopendan preparation for oral administration
JP4572293B2 (en) * 2004-07-21 2010-11-04 トーアエイヨー株式会社 Pimobendan oral dosage formulation
WO2007035874A1 (en) * 2005-09-21 2007-03-29 Bristol-Myers Squibb Company Oral administration of n-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-1,3-thiazole-5-carboxamide and salts thereof
JP4572300B2 (en) * 2006-01-19 2010-11-04 トーアエイヨー株式会社 Pimobendan oral dosage formulation
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
PE20081482A1 (en) * 2006-12-20 2008-12-23 Novartis Ag GELATINE CAPSULES CONTAINING AN ACID
FR2934156B1 (en) * 2008-07-23 2010-09-24 Virbac ORAL ADMINISTRATION MEDICAMENT IN SOLID FORM
WO2010055119A2 (en) * 2008-11-17 2010-05-20 Novartis Ag Pharmaceutical composition comprising pimobendan
DK2370070T3 (en) 2008-11-25 2013-12-02 Boehringer Ingelheim Vetmed Pimobendan for use in the treatment of hypertrophic cardiomyopathy in cats
NL1037569C2 (en) 2009-12-18 2011-06-21 Eurovet Animal Health B V Crystalline pimobendan, process for the preparation thereof, pharmaceutical composition and use.
KR20120116422A (en) * 2009-12-29 2012-10-22 코와 가부시키가이샤 Pharmaceutical composition for oral administration
JPWO2011081117A1 (en) * 2009-12-29 2013-05-09 興和株式会社 Solid pharmaceutical composition for oral administration
EP3167876B1 (en) 2012-03-15 2021-09-08 Boehringer Ingelheim Vetmedica GmbH Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
CN113197846A (en) 2013-07-19 2021-08-03 勃林格殷格翰动物保健有限公司 Liquid aqueous pharmaceutical composition containing preserved etherified cyclodextrin derivatives
EA034054B1 (en) 2013-12-04 2019-12-23 Бёрингер Ингельхайм Ветмедика Гмбх Improved pharmaceutical compositions of pimobendan
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
CN106729723A (en) * 2016-11-21 2017-05-31 青岛农业大学 A kind of pharmaceutical composition containing UD-CG115BS.acardi and preparation method thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8101067A1 (en) * 1978-08-25 1980-12-01 Thomae Gmbh Dr K Benzimidazoles, their preparation and pharmaceutical compositions containing them.
DE2837161A1 (en) * 1978-08-25 1980-03-06 Thomae Gmbh Dr K 5-Alkyl:pyridazinyl substd. benzimidazole derivs. - useful as cardiovascular agents, antivirals, interferon inducers and ulcer inhibitors
JPS56110612A (en) * 1980-02-08 1981-09-01 Yamanouchi Pharmaceut Co Ltd Readily disintegrable and absorbable compression molded article of slightly soluble drug
JPS60163823A (en) * 1984-02-03 1985-08-26 Taisho Pharmaceut Co Ltd Oral administration pharmaceutical
EP0266707B1 (en) * 1986-11-03 1992-01-22 Schering Corporation Sustained release labetalol tablet
DE3728244A1 (en) * 1987-08-25 1989-03-09 Thomae Gmbh Dr K Novel (-)-benzimidazoles, their preparation and medicaments containing these compounds
EP0306846A3 (en) * 1987-09-11 1990-05-02 Dr. Karl Thomae GmbH Synergistic combination comprising a phosphodiesterase inhibitor and a thromboxane-a2 antagonist, and its use or preparation
DE3805635A1 (en) * 1988-02-24 1989-09-07 Thomae Gmbh Dr K USE OF BENZIMIDAZOLES FOR THE MANUFACTURE OF A MEDICAMENT WITH ANTI-MIXIC EFFECTS ON THE HEART AND ITS COMBINATIONS WITH SS-BLOCKERS OR BRADYCARDICA
JPH01258621A (en) * 1988-04-06 1989-10-16 Fujimoto Seiyaku Kk Dilazep tablet with regulated absorption
JPH023609A (en) * 1988-06-21 1990-01-09 Fujimoto Seiyaku Kk Long-acting drug preparation containing nicardipine hydrochloride as active component

Also Published As

Publication number Publication date
PT96506A (en) 1991-10-15
CA2034569A1 (en) 1991-07-21
EP0439030A2 (en) 1991-07-31
AU630536B2 (en) 1992-10-29
HU207948B (en) 1993-07-28
JPH04210919A (en) 1992-08-03
DK0439030T3 (en) 1993-08-16
FI910263A (en) 1991-07-21
FI96274B (en) 1996-02-29
AU6945491A (en) 1991-07-25
HUT56494A (en) 1991-09-30
FI910263A0 (en) 1991-01-18
IE910165A1 (en) 1991-07-31
NZ236834A (en) 1995-10-26
EP0439030A3 (en) 1991-10-16
IL96995A0 (en) 1992-03-29
ZA91372B (en) 1992-09-30
IL96995A (en) 1994-11-11
EP0439030B1 (en) 1993-03-31
NO176305B (en) 1994-12-05
HK175796A (en) 1996-09-27
DE59100067D1 (en) 1993-05-06
IE64659B1 (en) 1995-08-23
DE4001622A1 (en) 1991-07-25
KR0163056B1 (en) 1998-12-01
NO176305C (en) 1995-03-15
PT96506B (en) 1998-06-30
ES2054379T3 (en) 1994-08-01
HU910177D0 (en) 1991-08-28
FI96274C (en) 1996-06-10
CA2034569C (en) 2002-03-19
KR910014120A (en) 1991-08-31
NO910213D0 (en) 1991-01-18
JP2608183B2 (en) 1997-05-07
ATE87481T1 (en) 1993-04-15

Similar Documents

Publication Publication Date Title
NO910213D0 (en) PROCEDURE FOR THE PREPARATION OF ORAL PHARMACEUTICAL FORMS OF PIMOBENDAN.
ITBO910024A1 (en) PHARMACEUTICAL FORMULATIONS CONTAINING GLYCOSAMINOGLICANS ABSORBABLE ORALLY.
NO912607D0 (en) ORAL, PHARMACEUTICAL DOSAGE FORM WITH PROGRAMMED RELEASE.
DZ1876A1 (en) Medicines for oral administration.
DE69104777D1 (en) Oral drug forms of biologically active proteins.
DE3679920D1 (en) SPIRO-3-HETEROAZOLIDINE COMPOUNDS AND THEIR SALTS, THEIR PRODUCTION AND THE PHARMACEUTICAL AGENTS CONTAINING THEM.
SE9201930D0 (en) GASTRIC ANTIBACTERIAL TREATMENT
ATE38151T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING STABLE 5-ADENOSYL-L-METHIONINE SALTS FOR ORAL USE.
DE69213183T2 (en) N'-cyanomethylethylenediamine-N, N'-diacetic acid, its salts and their preparation
DE515995T1 (en) N- (5-THIOXO-L-PROPYL) -L-CYSTEIN AND DERIVATIVES, THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS.
DE58903964D1 (en) LIQUID ORAL FORMULATION.
NO913019L (en) SOLID ORAL PREPARATION FORMS CONTAINING IFOSPHAMIDE AS ACTIVE SUBSTANCE.
DE3681856D1 (en) PHARMACEUTICAL 2-OXOPYRROLIDINE COMPOUNDS, THEIR SALTS AND THEIR PRODUCTION.
NO913644D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE AMINO ACID DERIVATIVES.
ATE165239T1 (en) ORAL MEDICINAL PREPARATION CONTAINING DICLOFENAC SODIUM AND AN ORGANIC ACID
ATE145333T1 (en) ORAL DRUGS CONTAINING HIRUDIN
DE69009765D1 (en) KYNURIC ACID DERIVATIVES, THEIR PRODUCTION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
ATE37539T1 (en) IMIDAZOLE DERIVATIVES AND SALTS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS.
DE3764233D1 (en) CYCLOPENTYLAETHER, THEIR PRODUCTION AND PHARMACEUTICAL FORMULATION.
KR970702034A (en) Low Dosage Ranitidine Compositions for the Treatment of Minor Gastrointestinal Disorders Associated with Excess Acid Secretion
FI902131A0 (en) KRISTALLINA MONO- OCH COPOLYMER AV PROPYLEN I FORM AV SFAERISKA PARTIKLAR MED HOEG POROSITET.
ATE78405T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING PIPERIDINACANOL DERIVATIVES.
IS4288A (en) 2,4-disulfonylphenylbutylnitron, its salts, pharmaceutical formulations together with the use of this compound in the manufacture of a medicament
ES2150400A6 (en) Pharmaceutical composition for treatment of ulcer type disorders of gastro-intestinal tract, comprises methyl polysiloxanol and solvent or carrier pharmaceutically acceptable for oral use

Legal Events

Date Code Title Description
MK1K Patent expired